JCB logo
Keystone Symposia
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published online July 14, 2008
doi:10.1083/jcb.200711040
The Journal of Cell Biology, Vol. 182, No. 1, 19-26
The Rockefeller University Press, 0021-9525 $30.00
© 2008 Bonetti et al.
This Article
Right arrow Full Text
Right arrow PDF (Full Text)
Right arrow PPT slides of all figures
Right arrow Supplemental Material index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Bonetti, P.
Right arrow Articles by Colombo, E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bonetti, P.
Right arrow Articles by Colombo, E.
Related Collections
Right arrowRelated Article
Right arrowRelated In this Issue article
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Report

 Nucleophosmin and its AML-associated mutant regulate c-Myc turnover through Fbw7{gamma}

Paola Bonetti1, Teresa Davoli1, Cristina Sironi1, Bruno Amati1, Pier Giuseppe Pelicci1,2,3, and Emanuela Colombo1,2

1 Department of Experimental Oncology, European Institute of Oncology, 20141 Milan, Italy
2 Dipartimento di Medicina, Chirurgia e Odontoiatria, University of Milano, 20122 Milan, Italy
3 The FIRC Institute of Molecular Oncology Foundation (IFOM), 20139 Milan, Italy

Correspondence to Emanuela Colombo: emanuela.colombo{at}ifom-ieo-campus.it; or Pier G. Pelicci: piergiuseppe.pelicci{at}ifom-ieo-campus.it

Mutations leading to aberrant cytoplasmic localization of nucleophosmin (NPM) are the most frequent genetic alteration in acute myelogenous leukemia (AML). NPM binds the Arf tumor suppressor and protects it from degradation. The AML-associated NPM mutant (NPMmut) also binds p19Arf but is unable to protect it from degradation, which suggests that inactivation of p19Arf contributes to leukemogenesis in AMLs. We report here that NPM regulates turnover of the c-Myc oncoprotein by acting on the F-box protein Fbw7{gamma}, a component of the E3 ligase complex involved in the ubiquitination and proteasome degradation of c-Myc. NPM was required for nucleolar localization and stabilization of Fbw7{gamma}. As a consequence, c-Myc was stabilized in cells lacking NPM. Expression of NPMmut also led to c-Myc stabilization because of its ability to interact with Fbw7{gamma} and delocalize it to the cytoplasm, where it is degraded. Because Fbw7 induces degradation of other growth-promoting proteins, the NPM–Fbw7 interaction emerges as a central tumor suppressor mechanism in human cancer.

P.G. Pelicci and E. Colombo contributed equally to this paper.

Abbreviations used in this paper: AML, acute myelogenous leukemia; ChIP, chromatin immunoprecipitation; CHX, cycloheximide; LMB, leptomycin B; MEF, mouse embryonic fibroblast; Myc-ER, Myc–estrogen receptor fusion protein; NPM, nucleophosmin; NPMmut, NPM mutant; OHT, hydroxytamoxifen; QPCR, quantitative PCR; WB, Western blot; WT, wild type.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article

Playing both sides: nucleophosmin between tumor suppression and oncogenesis
Pier Paolo Di Fiore
J. Cell Biol. 2008 182: 7-9. [Abstract] [Full Text] [PDF]

Related In this Issue article

NUCLEOPHOSMIN MUTATION IS DOUBLE TROUBLE
Richard Robinson
J. Cell Biol. 2008 182: 3. [Full Text] [PDF]



This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents